MMSF: Multitask and Multimodal Supervised Framework for WSI Classification and Survival Analysis
Chengying She, Chengwei Chen, Xinran Zhang, Ben Wang, Lizhuang Liu, Chengwei Shao, Yun Bian
TL;DR
MMSF introduces a linear-complexity multitask and multimodal framework for WSI classification and survival analysis that fuses patch-level graph context with instance-level clinical embeddings through a hierarchical fusion design. It replaces transformer-based MIL with a state space model-based Mamba backbone, enabling efficient processing of large patch sets (APS selects 512 patches) and delivering joint classification and survival predictions. The architecture combines a patch-level graph module, a clinical data embedding module, and an SE-based feature fusion mechanism to achieve state-of-the-art performance on CAMELYON16, TCGA-NSCLC, and five TCGA survival cohorts, with strong ablations validating each component. The approach offers clinically practical benefits through improved accuracy, interpretability via patch-score visualizations, and computational efficiency that supports deployment in real-world pathology workflows.
Abstract
Multimodal evidence is critical in computational pathology: gigapixel whole slide images capture tumor morphology, while patient-level clinical descriptors preserve complementary context for prognosis. Integrating such heterogeneous signals remains challenging because feature spaces exhibit distinct statistics and scales. We introduce MMSF, a multitask and multimodal supervised framework built on a linear-complexity MIL backbone that explicitly decomposes and fuses cross-modal information. MMSF comprises a graph feature extraction module embedding tissue topology at the patch level, a clinical data embedding module standardizing patient attributes, a feature fusion module aligning modality-shared and modality-specific representations, and a Mamba-based MIL encoder with multitask prediction heads. Experiments on CAMELYON16 and TCGA-NSCLC demonstrate 2.1--6.6\% accuracy and 2.2--6.9\% AUC improvements over competitive baselines, while evaluations on five TCGA survival cohorts yield 7.1--9.8\% C-index improvements compared with unimodal methods and 5.6--7.1\% over multimodal alternatives.
